Literature DB >> 3844325

The effect of null C4 alleles on complement function.

T R Welch, L Beischel, A Berry, J Forristal, C D West.   

Abstract

C4 is encoded at two polymorphic genetic loci (C4A and B), and "null" or unexpressed alleles are relatively common. An increased frequency of nulls has been reported in a variety of diseases. In the present study, C4 allotypes and C4 hemolytic efficiencies (the ratios of functional to antigenic levels) were determined for a population of 75 normal unrelated individuals. Of these, 28 had three gene products (single null at C4A or B) while three had no expressed C4A products and three had no C4B products (homozygous null). Mean antigenic C4 levels correlated with the number of expressed gene products but there was a wide spread of individual values. Those homozygous null for C4A had greater, and for C4B less, hemolytic efficiency than those with four gene products. However, there was no difference in the in vitro kinetics of C3 convertase formation between homozygous null C4A or C4B individuals. Therefore, the presence of null genes for C4 does not appear to compromise complement function sufficiently to account for the reported disease associations. Some of the associations may result from the fact that null genes for C4, as part of an extended HLA haplotype, may be genetically linked to disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3844325     DOI: 10.1016/0090-1229(85)90180-1

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  13 in total

Review 1.  The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.

Authors:  J F Knight
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

2.  Can one predict the prognosis in patients with IgA nephropathy from the analysis of serum complement?

Authors:  R J Wyatt
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

3.  Difference in the biological properties of the two forms of the fourth component of human complement (C4).

Authors:  J A Schifferli; G Steiger; J P Paccaud; A G Sjöholm; G Hauptmann
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

4.  Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles.

Authors:  G Uko; F T Christiansen; R L Dawkins; V J McCann
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

5.  Uniparental isodisomy 6 associated with deficiency of the fourth component of complement.

Authors:  T R Welch; L S Beischel; E Choi; K Balakrishnan; N A Bishof
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Major histocompatibility complex antigens in steroid-responsive nephrotic syndrome.

Authors:  P T McEnery; T R Welch
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

Review 7.  Renal disease associated with inherited disorders of the complement system.

Authors:  Thomas R Welch; Lisa W Blystone
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

8.  Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins.

Authors:  Erwin K Chung; Yan Yang; Kristi L Rupert; Karla N Jones; Robert M Rennebohm; Carol A Blanchong; C Yung Yu
Journal:  Am J Hum Genet       Date:  2002-09-10       Impact factor: 11.025

9.  Serum C4 concentration in the monitoring of systemic lupus erythematosus: requirement for C4 allotyping.

Authors:  G Uko; F T Christiansen; R L Dawkins
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

10.  C4 uremic variant: an acquired C4 allotype.

Authors:  T R Welch; L Beischel
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.